‘Halo-like’ device fits on head to quickly bust clots
A new device developed by a physician at the University of Arkansas for Medical Sciences and a researcher at the University of Arkansas at Little Rock could soon be available to treat stroke more effectively.
The ClotBust ER® fits on the head like a halo and delivers therapy to quickly bust clots that cause stroke.
It was developed by William Culp, M.D., professor of radiology, surgery and neurology and vice chairman of research at UAMS, and Doug Wilson, assistant director at the Graduate Institute of Technology at UALR.
Culp has spent many years studying therapy for stroke. One element of Culp’s work included using ultrasound in combination with the clot-busting drug tissue plasminogen activator (t-PA).
While looking into the treatment to dissolve clots in blood vessels, Culp realized one problem is getting the ultrasound to operate through the skull. Ultrasound can be delivered anywhere in a patient’s body unless the waves hit something hard like bone or something very soft, like air.
“We realized we had trouble delivering ultrasound to the vessels at the base of the brain,” Culp said. “The skull stopped the ultrasounds.”
He teamed with Wilson to brainstorm ideas about how to get the ultrasound waves to reach the clot in stroke patients.
“This is a great example of how faculty at both schools can partner to develop new technologies. The success of this research will foster ties between the two campuses,” Wilson said.
“It makes me extremely proud to have contributed to a product with potential to help many people,” he said.
Culp received an $8,000 grant from UAMS that provided him with the materials he needed to experiment. Wilson and Culp completed their first patent for “ultrasound for augmented clot lysis” in 2005. The patent was licensed in 2006 and has been in development by Cerevast Therapeutics.
The ClotBust ER® has 16 transducers scattered around the inside – designed to line up with the thin points in the skull: the temples and the foramen magnum in the base of the skull.
This allows the ultrasound waves to move through the brain without interruption. After the patient is administered an IV containing t-PA, the circular device is placed onto the patient’s head like a sports visor or halo.
“The idea is to deliver ultrasound wherever the clot is and where the IV t-PA is working,” Culp said. “It makes t-PA work better – improving the clot-busting drug by 40 or 50 percent. It’s like taking a cooking pot and stirring it. The ultrasound stirs the drug around, making it work better.”
The clot disappears more quickly. “If we resupply blood, we resupply oxygen. The brain recovers quicker. Quicker is, of course, better,” Culp said.
The Latest on: Stroke treatment
via Google News
The Latest on: Stroke treatment
Colchicine cuts odds of new heart attack, stroke in heart attack survivors
on November 18, 2019 at 11:50 am
(Reuters Health) - The inflammation-fighting drug colchicine, already a treatment for gout, dramatically reduces the odds of future cardiovascular problems in people who have just survived a heart ...
Lower LDL Target Better After Stroke
on November 18, 2019 at 11:49 am
Overall, 86% of the patients had proven ischemic stroke on MRI. In the lower target group, ezetimibe (Zetia) was added to statin treatment in 33%, compared with 5% in the higher target group. Patients ...
Lower Cholesterol Cuts CV Events: Treat Stroke to Target Trial
on November 18, 2019 at 11:02 am
PHILADELPHIA, PA—Prescribing statins to achieve a more aggressive LDL treatment target in patients who have had a TIA or ischemic stroke of atherosclerotic origins reduces the risk of major ...
15-year study finds treatment gaps exist for patients with peripheral arterial disease
on November 18, 2019 at 12:12 am
From 1999 through 2013, a statin prescription increased in five-year increments from 17% to 37% to 48%, indicating steady progress toward the 100% ultimate treatment goal. However, the most recent ...
Napa’s NeuroSpring develops new medical treatments for stroke patients
on November 16, 2019 at 3:00 pm
“We’re trying to learn about something we don’t already know about,” said Ballesteros. By studying the rats’ brains, he hopes to determine if a NeuroSpring treatment can affect the animal’s brain when ...
Treatment to ward off stroke less effective in women
on November 15, 2019 at 5:54 am
a key risk factor for stroke. "Men and women are different and sometimes their disease might call for a different treatment approach," said the study's lead investigator Niveditta Ramkumar, a graduate ...
Stroke among cancer patients
on November 15, 2019 at 2:22 am
Our work has limitations. The overall number of deaths from stroke was relatively limited overall (1% of cancer patients), and more detailed analyses on risk factors could not be performed. Treatment ...
Stroke Prevention in Atrial Fibrillation (SPAF) Treatment Market to Witness Huge Growth by 2026: Evaluating By Global Leading Players
on November 13, 2019 at 10:05 pm
Nov 14, 2019 (Market Prediction via COMTEX) -- A new research report titled “Global Stroke Prevention in Atrial Fibrillation (SPAF) Treatment market” successfully exhibits the complete scenario of the ...
New Results: Brainomix Software Shown to Improve Stroke Treatment Rates at Budapest University Hospital
on November 13, 2019 at 4:09 pm
Results Showed e-Stroke Suite Associated with Increase in Thrombolysis and Thrombectomy Treatment Rates for Stroke Patients OXFORD, England, Nov. 12, 2019 /PRNewswire/ -- Last Friday during a ...
Acute Ischemic Stroke Diagnosis and Treatment Market In Deep Analysis and Research on Health Segment 2025
on November 11, 2019 at 10:33 am
Nov 11, 2019 (Market Insight Reports via COMTEX) -- The Acute Ischemic Stroke Diagnosis and Treatment Market recently Published Global Market research study with more than 100 industry informative ...
via Bing News